“How long should we follow patients managed for muscle-invasive bladder cancer? Lesson learned from a recent clinical practice”, Arch Ital Urol Androl, vol. 94, no. 3, pp. 369–370, Sep. 2022, doi: 10.4081/aiua.2022.3.369.